The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinson's disease

Movement Disorders

Volumn 23, Issue 7, 2008, Pages 1043-1046

  Gill, David J ^a,c   Freshman, Arielle ^a   Blender, Jennifer A ^b   Ravina, Bernard ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cognition; Parkinson's disease; Screening

Indexed keywords

AGED; APTITUDE TEST; ARTICLE; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HUMAN; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; SCREENING TEST; TEST RETEST RELIABILITY; VALIDITY; DEPTH PERCEPTION; HOSPITALIZATION; MASS SCREENING; PHYSIOLOGY; PSYCHOMETRY; VALIDATION STUDY; VISION;

AGED; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MASS SCREENING; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; SPACE PERCEPTION; VISUAL PERCEPTION;

EID: 49249101596     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22017     Document Type: Article

References (19)

1. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The campaign study. Brain 2004;127(Pt 3):550-560.
2. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005;65:1239-1245.
3. Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003;60:387-392.
4. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
5. Marinus J, Visser M, Verwey NA, et al. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-12228.
6. Biggins CA, Boyd JL, Harrop FM, et al. A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1992;55:566-571.
7. Nasreddine ZS, Phillips NA, Bedirian V, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-699.
8. Mahieux F, Fenelon G, Flahault A, Manifacier MJ, Michelet D, Boller F. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998;64:178-183.
9. Janvin CC, Larsen JP, Aarsland D, Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 2006;21:1343-1349.
10. Caviness JN, Driver-Dunckley E, Connor DJ, et al. Defining mild cognitive impairment in Parkinson's disease. Mov Disord 2007;22:1272-1277.
11. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
12. Sheik JI, Yesavage JA. Geriatric depression scale. Recent evidence and development of a shorter version. In: Brink TL, editor. Clinical gerontology; a guide to assessment and intervention. New York: Howarth Press; 1986. p 165-173.
13. Uekermann J, Daum I, Peters S, Wiebel B, Przuntek H, Muller T. Depressed mood and executive dysfunction in early Parkinson's disease. Acta Neurol Scand 2003;107:341-348.
14. Brandt J, Benedict RHB. Hopkins verbal learning test - revised. professional manual Lutz, FL: Psychological Assessment Resources; 2001.
15. Wechsler D. Wechsler adult intelligence Scale - third revision. (WAIS-III) San Antonio, TX Psychological Corporation; 1997.
16. Comalli PE, Jr, Wapner S, Wemer H. Interfernce effects of stroop color-word test in childhood, adulthood, and aging. J Genet Psychol 1962;100:47-53.
17. Lezak M. Neuropsychological assessment. New York: Oxford University Press; 1995.
18. Petersen RC, Smith GE, Ivnik RJ, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995;273:1274-1278.
19. Fleiss JL. The design and analysis of clinical experiments. New York: Wiley; 1986.